NASDAQ:RIGL opened at $20.20 on Wednesday. Rigel Pharmaceuticals has a 1-year low of $7.48 and a 1-year high of $29.82. The business has a 50 day moving average of $20.91 and a 200 day moving ...

LCSO is selling pink-and-black T-shirts with the sheriffs department logo and a breast cancer logo. All proceeds from those ...

Commercial strength continued in the fourth quarter for all products with record bottles shipped to patients and clinics and total bottles sold. The following table summarizes total bottles ...

SOUTH SAN FRANCISCO, Calif., March 10, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Mark W. Frohlich, M.D. to ...

Greetings and welcome to Rigel Pharmaceuticals Financial Conference Call for the Fourth Quarter and Full Year 2024. [Operator Instructions] As a reminder, this conference is being recorded.

Rigel Pharmaceuticals has a 12-month low of $7.48 and a 12-month high of $29.82. The company’s 50 day moving average price is $19.58 and its two-hundred day moving average price is $18.07.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Rigel Pharmaceuticals Inc. (RIGL) on Tuesday reported fourth-quarter earnings of $14.3 million. On a per-share basis ...

On March 6, 2025, Rigel Pharmaceuticals Inc. (NASDAQ:RIGL), a company specializing in pharmaceutical preparations with a market capitalization of $347 million and impressive revenue growth of 55% over ...

These increases were partially offset by decreased research and development costs due to the timing of clinical trial activities related to R289, Rigel's dual IRAK 1/4 inhibitor program ...